Clinical Trials in France / NCT05267041
Recruiting
Not applicable
Joint Thoracic Oncology Research Unit of LYon: Lung cancerS DatabaSE (ULYSSE)
NCT05267041 · tracked via the Priya Life Science France tracker
Condition(s) studied
Lung Cancer
Investigational drug(s) / intervention(s)
Blood sample →Questionnaire
Blood sample: One optional veinous blood sampling (24 ML) between the first diagnostic annoucement and before the first treatment for lung cancer
Questionnaire: to collect data not reported in the patient's medical file, such as passive smoking, family history of cancer, and attempts to quit smoking.
Study summary
Prospective longitudinal cohort associated to blood collection, pathological samples collection, and radiological and pathological imaging collection.
Eligibility
Inclusion Criteria:
* Patient treated for a thoracic cancer in the Lyon University Hospital: non-small cell lung cancer, small cell lung cancer, mesothelioma…
* Diagnosis can be done:
* By cytology or pathologic assessment
* Or by multidisciplinary team meeting decision:
* Irradiation without morpho-metabolic sampling
* Treatment without sampling based on non-invasive molecular data
Exclusion Criteria:
\- Refusal to participate
For optional blood sampling :
* \< 30 kg for blood collection
* No blood sampling schedule for care
Primary outcome measure(s)
- Number of participants registered in the lung cancer database — 20 years
cohort open to recruitment during 10 years with 10 years of patients follow-up
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Centre Hospitalier Lyon Sud | Pierre-Bénite | France | Recruiting |
More Hospices Civils de Lyon trials in France
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05267041 on ClinicalTrials.gov ↗ ← All trials in France